glp-1 rekulo and the kidney: from physiology to pharmacology and outcomes in diabetes How GLP-1 medications are transforming
Description
Lee HH, Chang CH, Wang LJ, Wu CC, Chen HL, Lu T, et al
10.1016/S2213-8587(19)30422-X Summary Keywords GLP-1 receptor agonists, diabetes, coronary artery disease, acute and chronic coronary syndromes, atherosclerosis, coronary microcirculation Citation Pahud de Mortanges A, Sinaci E, Salvador Jr D, Bally L, Muka T, Wilhelm M and Bano A (2022) GLP-1 Receptor Agonists and Coronary Arteries: From Mechanisms to Events
PLoS ONE, 7, e45167
others start it at delivery
In Hashimoto's patients, this baseline inflammatory state is already elevated due to the autoimmune attack on the thyroid gland
